Here are five observations:
1. The market will likely hit $34.7 billion by 2024, up from $16.6 billion in 2016.
2. The rising number of sports injuries and growing adoption of arthroscopic surgeries are spurring market growth.
3. Demand for bone graft substitutes, surgical devices and arthroscopy devices is growing in the market.
4. In 2016, Arthrex accounted for the greatest market share, with Smith & Nephew, DePuy Synthes, Stryker and CONMED following close behind.
5. Johnson & Johnson, Bird & Cronin, Zimmer Biomet, Anika Therapeutics, Ossur, Breg, Mueller Sports Medicine, DJO Global and Medtronic are also key market players.
More articles on sports medicine:
2 concerns keeping Dr. Rick White up at night & what’s exciting in sports medicine
Drs. Luga Podesta, William McCafferty & more: 5 sports medicine physicians on the move
Dr. Allen Sills defends Colts decision allowing quarterback Jacoby Brissett to play after late concussion diagnosis
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.